Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feru-guard for Behavioral Symptoms in Dementia
NCT03451760Phase 2Unknown
- Sponsor
- Glovia
- Start
- Sep 2018
- Primary completion
- Dec 2019
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by Glovia. Primary endpoint: Neuropsychiatric Inventory Questionnaire Total Score at 12 weeks. Status: unknown.
Beyond the preview
Go deeper on NCT03451760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03451760.